NPI 1619932084: Open Payments
NPI 1619932084. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$800 in 25 payments from 6 companies in 2025. Trend: 2023 $83 · 2024 $206 · 2025 $800
Food & beverage: $800
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 13 | $329 |
| Gilead Sciences, Inc. | 6 | $234 |
| ViiV Healthcare Company | 1 | $122 |
| Indivior Inc. | 2 | $49 |
| Alkermes, Inc. | 1 | $34 |
| ABBVIE INC. | 2 | $32 |
Products named: BRIXADI, APRETUDE, Yeztugo, SUBLOCADE, VIVITROL, MAVYRET.
